What did @cristina.noh actually say?
She laid out a fairly elaborate daily protocol. Mornings include GHK-Cu alone, then BPC-157 for what she calls "cellular repair," plus something she calls MOTC for "metabolism support." Nights involve two compounds she refers to as "epitheal" and "someroline for sleep cycles." Once a week she takes "red effort, GLP3" alongside something called "bean talk," and she's had to reduce doses on both because she's "dropping weight like crazy." She also uses a compound she calls "Calgary" as an appetite suppressant and does glutathione a couple of times a week.
One thing she said that's actually worth noting: she explicitly stated she has guidance from "someone who really knows what they're doing" and doesn't earn commission on any products. That disclaimer matters, even if it's not enough on its own to validate the protocol.
A significant problem here is that several compound names she uses, MOTC, epitheal, someroline, red effort, Calgary, bean talk, don't match any recognized peptide nomenclature. They're either brand names, misspellings, or proprietary blends whose ingredients aren't disclosed in the video.
Does the science back this up?
For the compounds we can actually identify, the evidence is uneven. GHK-Cu has legitimate research behind it, mostly in skin biology. BPC-157 has real preclinical data, mostly in rodents. The GLP-1 class she appears to reference has robust clinical trial data. Everything else is a black box.
GHK-Cu (copper peptide) has been studied in wound healing and skin remodeling contexts, with Pickart and Margolina (2018, Cosmetics) summarizing its role in collagen synthesis and antioxidant gene expression. That work is real, though mostly in vitro or small human studies. BPC-157 has shown tissue repair effects in animal models, including Sikiric et al. (2018, Current Pharmaceutical Design), but zero completed human clinical trials exist as of this writing. The weight loss she attributes to her weekly "GLP3" injection is consistent with how GLP-1 receptor agonists like semaglutide work, per Wilding et al. (2021, NEJM), but she never identifies the compound by its actual name, which is a meaningful gap. Glutathione IV or subcutaneous use is popular but evidence for systemic antioxidant benefit remains limited, per Pizzorno (2014, Integrative Medicine).
What did they get wrong (or right)?
The biggest problem isn't the individual compounds, it's the unidentifiable ones. When a creator names half their stack using terms that don't correspond to anything in the peptide literature or any known compound database, that's not a minor detail. It makes independent verification impossible.
She's also stacking compounds with overlapping mechanisms without explaining the rationale. BPC-157 and GHK-Cu both influence tissue repair pathways. Running a GLP-1 class drug weekly alongside an additional "appetite suppressant" compound she calls Calgary raises real questions about synergistic risk. Weight loss fast enough that you have to "come down on the dose" is a signal worth taking seriously, not just a side note.
What she got right: she didn't claim to cure anything. She didn't tell viewers to copy her doses. She acknowledged professional guidance. Those are low bars, but in this content category, they're bars a lot of creators don't clear.
What should you actually know?
If you're watching stacking videos on TikTok and thinking about replicating them, there are a few things to understand about where the science actually stands.
- BPC-157 has never completed a human clinical trial. Every claim about it in humans is extrapolated from animal studies.
- GHK-Cu's skin benefits have the most evidence, but "glow" results shown in videos are not controlled conditions.
- GLP-1 receptor agonists are FDA-regulated drugs. Compounded versions are not equivalent to branded products and carry their own regulatory and quality considerations.
- Stacking multiple peptides isn't studied. We don't have interaction data because no one has run those trials.
- The compounds in this video that have no recognizable names cannot be fact-checked. That alone should give viewers pause before treating this as a template.
Having a practitioner guiding your protocol, as she mentioned, is genuinely better than self-prescribing. But that doesn't validate the protocol itself, and it doesn't replace the missing evidence base for most of what she's using.